Form 8-K - Current report:
SEC Accession No. 0001213900-14-005334
Filing Date
2014-08-04
Accepted
2014-08-04 08:16:13
Documents
3
Period of Report
2014-08-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k080414_actiniumpharma.htm 8-K 17668
2 PRESS RELEASE f8k080414ex99i_actinium.htm EX-99.1 24578
3 GRAPHIC img01.jpg GRAPHIC 6901
  Complete submission text file 0001213900-14-005334.txt   53063
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 141011543
SIC: 6770 Blank Checks